Caliway Biopharmaceuticals (6919.TW) Q4 2025 Earnings

7NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-1.36
-0.91
-0.46
-0.01

Details

Expected EPS
-0.19293276740100002
Actual EPS
-0.005046715020963
Surprise EPS
0.19
Surprise Percent
+97.38%

Description

Caliway Biopharmaceuticals (6919.TW) has reported earnings of -0.005046715020963 per share for Q4 2025.

0 Comments

Share your thoughts